BioAge Labs, Inc.(BIOA)
$5.87+0.09 (+1.56%)
BIOA
BioAge Labs, Inc. financials statements
$5.87
At close:+0.09 (+1.56%)
Want to see BIOA full AI Analyst Report?
BioAge Labs, Inc. (BIOA) Ratios
160 Followers
BioAge Labs, Inc. Ratios
BIOA's free cash flow for Q3 2026 was $-30.98M. For the 2026 fiscal year, BIOA's free cash flow was decreased by $-18.00K and operating cash flow was $-30.96M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 14.24 | 12.86 | 0.44 | 4.78 |
| Quick Ratio | 14.24 | 12.86 | 0.44 | 4.78 |
| Cash Ratio | 9.38 | 12.76 | 0.37 | 4.72 |
| Solvency Ratio | -3.52 | -2.02 | -0.32 | -0.28 |
| Operating Cash Flow Ratio | -4.05 | -1.85 | -0.64 | -6.17 |
| Short-Term Operating Cash Flow Coverage | -30.83 | -8.59 | -0.83 | -216.65 |
| Net Current Asset Value | $ 263.95M | $ 322.00M | $ -174.01M | $ -112.96M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.02 | 0.02 | 2.05 | 0.09 |
| Debt-to-Equity Ratio | 0.02 | 0.03 | -0.31 | -0.02 |
| Debt-to-Capital Ratio | 0.02 | 0.03 | -0.44 | -0.02 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.01 | -0.05 | -0.02 |
| Financial Leverage Ratio | 1.08 | 1.11 | -0.15 | -0.25 |
| Debt Service Coverage Ratio | -23.83 | -8.20 | -1.06 | -96.45 |
| Interest Coverage Ratio | -133.11 | -33.04 | -6.21 | -165.85 |
| Debt to Market Cap | 0.01 | 0.04 | 0.39 | 0.02 |
| Interest Debt Per Share | 0.17 | 0.31 | 8.18 | 0.36 |
| Net Debt to EBITDA | 2.30 | 5.04 | -0.57 | 0.64 |
| Profitability Margins | ||||
| Gross Profit Margin | 100.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -888.36% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -885.99% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -1031.46% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -896.11% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -896.11% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -896.11% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 86.88% | 90.94% | 131.93% | 99.38% |
| Return on Assets (ROA) | -27.33% | -19.85% | -246.31% | -139.72% |
| Return on Equity (ROE) | -29.63% | -22.01% | 36.83% | 35.29% |
| Return on Capital Employed (ROCE) | -33.77% | -23.66% | 150.11% | -177.10% |
| Return on Invested Capital (ROIC) | -33.38% | -23.23% | -377.92% | -175.43% |
| Return on Tangible Assets | -27.33% | -19.85% | -246.31% | -139.72% |
| Earnings Yield | -16.96% | -34.26% | -46.72% | -29.08% |
| Efficiency Ratios | ||||
| Receivables Turnover | 11.70 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 2.40 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.03 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.03 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 31.20 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 31.20 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 31.20 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -2.27 | -1.44 | -5.00 | -4.85 |
| Free Cash Flow Per Share | -2.29 | -1.45 | -5.03 | -4.86 |
| Dividend Paid and CapEx Coverage Ratio | -113.53 | -140.77 | -225.07 | -351.27 |
| Capital Expenditure Coverage Ratio | -113.53 | -140.77 | -225.07 | -351.27 |
| Operating Cash Flow Coverage Ratio | -14.68 | -5.92 | -0.70 | -14.66 |
| Operating Cash Flow to Sales Ratio | -9.07 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -17.32% | -25.00% | -27.46% | -26.56% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -5.91 | -2.92 | -2.14 | -3.44 |
| Price-to-Sales (P/S) Ratio | 52.85 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.75 | 0.64 | -0.79 | -1.21 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.77 | -4.00 | -3.64 | -3.76 |
| Price-to-Operating Cash Flow Ratio | -5.82 | -4.03 | -3.66 | -3.78 |
| Price-to-Earnings Growth (PEG) Ratio | -0.45 | -0.50 | -0.04 | 0.00 |
| Enterprise Value Multiple | -3.66 | 2.01 | -3.01 | -2.83 |
| Enterprise Value | 292.06M | -138.07M | 168.29M | 111.42M |
| EV to EBITDA | -3.66 | 2.01 | -3.01 | -2.83 |
| EV to Sales | 32.47 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -3.55 | 2.66 | -4.48 | -3.07 |
| EV to Operating Cash Flow | -3.58 | 2.68 | -4.50 | -3.08 |
| Tangible Book Value Per Share | 7.57 | 9.01 | -23.23 | -15.09 |
| Shareholders’ Equity Per Share | 7.57 | 9.01 | -23.23 | -15.09 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.25 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -2.24 | -1.98 | -8.55 | -5.32 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.03 | 1.14 | 1.01 |
| Research & Development to Revenue | 8.22 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 3.09 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 1.30 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.01 | 0.72 | 0.59 | 0.91 |
Currency in USD
